Combination of mTOR and EGFR Kinase Inhibitors Blocks mTORC1 and mTORC2 Kinase Activity and Suppresses the Progression of Colorectal Carcinoma

• Quan Wang ,

  Contributed equally to this work with: Quan Wang, Feng Wei

  * E-mail: wangquan-jlcc@hotmail.com (QW); chao@emory.edu (CH)

  Affiliation Department of Gastrointestinal Surgery, First Hospital of Jilin University, Changchun, Jilin, China

  ⨯
• Feng Wei ,

  Contributed equally to this work with: Quan Wang, Feng Wei

  Affiliation Department of Hepatopancreatobiliary Surgery, First Hospital of Jilin University, Changchun, Jilin, China

  ⨯
• Chunsheng Li,

  Affiliation Department of Colorectal Surgery, Third Hospital of Jilin University, Changchun, Jilin, China

  ⨯
• Guoyue Lv,

  Affiliation Department of Hepatopancreatobiliary Surgery, First Hospital of Jilin University, Changchun, Jilin, China

  ⨯
• Guangyi Wang,

  Affiliation Department of Hepatopancreatobiliary Surgery, First Hospital of Jilin University, Changchun, Jilin, China

  ⨯
• Tongjun Liu,

  Affiliation Department of Colorectal Surgery, Third Hospital of Jilin University, Changchun, Jilin, China

  ⨯
• Anita C. Bellail,

  Affiliation Department of Pathology & Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America

  ⨯
• Chunhai Hao

  * E-mail: wangquan-jlcc@hotmail.com (QW); chao@emory.edu (CH)

  Affiliation Department of Pathology & Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America

  ⨯